235
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Transverse Needling After Autologous Mini-Punch Grafts Improves Repigmentation in Stable Non-Segmental Vitiligo

, & ORCID Icon
Pages 827-835 | Published online: 06 Jul 2021

References

  • Razmi TM, Afra TP, Parsad D. Vitiligo surgery: a journey from tissues via cells to the stems! Exp Dermatol. 2019;28(6):690–694. doi:10.1111/exd.13807
  • Mulekar SV, Isedeh P. Surgical interventions for vitiligo: an evidence-based review. Br J Dermatol. 2013;169(Suppl.3):57–66. doi:10.1111/bjd.12532
  • Chen J, Wan Y, Lin Y, Jiang H. Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: a meta-analysis. Int Wound J. 2020;27.
  • Esquivel D, Mishra R, Srivastava A. Stem cell therapy offers a possible safe and promising alternative approach for treating vitiligo: a Review. Curr Pharm Des. 2020;26(37):4815–4821. doi:10.2174/1381612826666200730221446
  • Kim WI, Kim S, Lee SH, Cho MK. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet-B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis. Lasers Med Sci. 2021;36(1):165–173. doi:10.1007/s10103-020-03069-0
  • Salloum A, Bazzi N, Maalouf D, Habre M. Microneedling in vitiligo: a systematic review. Dermatol Ther. 2020;33(6):e14297. doi:10.1111/dth.14297
  • Benzekri L, Gauthier Y. Clinical markers of vitiligo activity. J Am Acad Dermatol. 2017;76(5):856–862. doi:10.1016/j.jaad.2016.12.040
  • Kanwar AJ, Mahajan R, Parsad D. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. J Cutan Med Surg. 2013;17(4):259–268. doi:10.2310/7750.2013.12053
  • Mohammad TF, Hamzavi IH, Lim HW. Phototherapy and PUVA. In: Lim H, Kohen L, Schneider S, Yeager D, editors. Practical Guide to Dermatology. Cham: Springer; 2020:167–175.
  • Eleftheriadou V, Hamzavi I, Pandya AG, et al. International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation. Br J Dermatol. 2019;180(3):574–579. doi:10.1111/bjd.17013
  • Ahmad T, Rashid T, Rani Z. Needling: an adjunct to narrowband ultraviolet-B therapy in localized fixed vitiligo. J Pak Assoc Dermatol. 2016;18:149–153.
  • Lahiri K, Malakar S. The concept of stability of vitiligo: a reappraisal. Indian J Dermatol. 2012;57(2):83–89. doi:10.4103/0019-5154.94271
  • Lee DY, Choi SC, Lee JH. Generalized vitiligo treated by combination therapy of epidermal graft and systemic corticosteroid. Clin Exp Dermatol. 2009;34(7):838. doi:10.1111/j.1365-2230.2009.03478.x
  • Lee DY, Lee KJ, Choi SC, Lee JH. Segmental vitiligo treated by the combination of epidermal grafting and systemic corticosteroids. Dermatol Surg. 2010;36(4):575–576. doi:10.1111/j.1524-4725.2010.01506.x
  • Banerjee K, Barbhuiya JN, Ghosh AP, Dey SK, Karmakar PR. The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patient. Indian J Dermatol Venereol Leprol. 2003;69:135–137.
  • Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013;206(3):410–417. doi:10.1016/j.amjsurg.2012.11.018
  • Forschner T, Buchholtz S, Stockfleth E. Current state of vitiligo therapy--evidence-based analysis of the literature. J Dtsch Dermatol Ges. 2007;5(6):467–475. doi:10.1111/j.1610-0387.2007.06280.x
  • Rajagopal R, Murthy S, Kar K, Vijendran P. Autologous miniature punch grafting in stable vitiligo. Indian J Dermatol. 2005;50:196–199.
  • Chandrashekar B, Madura C, Varsha D. Autologous mini punch grafting: an experience of using motorized power punch in 10 patients. J Cutan Aesthet Surg. 2014;7(1):42–45. doi:10.4103/0974-2077.129977
  • Van-geel N, Vandendriessche D, Vandersichel E, et al. Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis. Br J Dermatol. 2019;180(5):1198–1205. doi:10.1111/bjd.17190
  • Harris JE, Rashighi M, Nguyen N, et al. Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). J Am Acad Dermatol. 2016;74:(2):370–371. doi:10.1016/j.jaad.2015.09.073
  • Eleftheriadou V, Thomas KS, Whitton ME, Batchelor JM, Ravenscroft JC. Which outcomes should we measure in vitiligo? Results of a systematic review and a survey among patients and clinicians on outcomes in vitiligo trials. Br J Dermatol. 2012;167(4):804–814. doi:10.1111/j.1365-2133.2012.11056.x
  • Zawar VP, Karad GM. Needling in unresponsive stable vitiligo. J Am Acad Dermatol. 2016;75(5):e199–e200. doi:10.1016/j.jaad.2016.05.033
  • Frączek A, Owczarczyk-Saczonek A, Placek W. The role of TRM cells in the pathogenesis of vitiligo-a review of the current state-of-the-art. Int J Mol Sci. 2020;21(10):3552. doi:10.3390/ijms21103552
  • Rajaram M, Selvaraj U, Alagarsamy S. Punch skin graft in stable vitiligo: donor and recipient site changes-A retrospective Study. Int J Sci Study. 2017;5(5):232–238.
  • Das SS, Pasricha JS. Punch grafting as a treatment for residual lesions of vitiligo. Indian J Dermatol Venereol Leprol. 1992;58(5):315.
  • Malakar S, Dhar S. Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1000 patients. Dermatology. 1999;198(2):133–139. doi:10.1159/000018089
  • Boersma BR, Westerhof W, Bos JD. Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients. J Am Acad Dermatol. 1995;33(6):990–995. doi:10.1016/0190-9622(95)90292-9
  • Ebrahim HM, Albalate W. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment. J Cosmet Dermatol. 2020;19(4):855–862. doi:10.1111/jocd.13304
  • Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion, and type of disease on outcome. J Am Acad Dermatol. 2003;49(1):99–104. doi:10.1067/mjd.2003.415